Bioxis is a french biopharmaceutical that specializes in the clinical development and production of innovative regenerative medical devices based on patented biomaterials technology. The fast growing business is focused on developing injectable solutions and biomaterial products that help regenerate tissues and improve patient outcomes. Furthermore, Bioxis contributes to develop better healthcare opportunities that meet the doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine.



Bioxis Pharmaceuticals is especially known for their unique expertise in rheology and their Cytosial range. Cytosial is a range of three hyaluronic acid dermal filler used to reduce the signs of aging: Cytosial Deep, Cytosial Medium and Cytosial Volume. The Cytosial range uses a new way of stabilizing hyaluronic acid to provide long lasting effects, improve the rheological performance and ensure high safety.

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.